comparative study of cefpodoxime
DESCRIPTION
TRANSCRIPT
Comparative study of Cefpodoxime
and to study the market potential for
’s product portfolio.
Started by Ranbir Singh and Gurbax
Singh 1937
Incorporated in
1961 and went public in 1973
June 2008, with Daiichi Sankyo
Ranbaxy & Daiichi Sankyo combined rank top 20 global pharmaceutical companies.
In public
Merger
Position
No. 1 Indian Pharma Company Global consolidated sales –US $ 1519 Mn (2009)
International 77%
Domestic 23%
Ginseng
Ofloxacin
Valacyclovir
Ciprofloxacin
Diclofenac
Amoxycillin
Cefpodoxime
Atorvastatin
Cephalexin
Ceftriaxone
Isotretinoin
Rantidine
Imipenem
Co-amoxyclav
Loratadine
Ketorolac
Simvastatin
(Cefpodoxime proxetil) is an orally administered, extended spectrum, semi-syntheticantibiotic of the cephalosporin class.
Microbiology:
Cefpodoxime is active against a wide spectrum of Gram-positive and Gram-negative bacteria. Cefpodoxime is stable in the presence of beta-lactamase enzymes. As a result, many organisms resistant to penicillins and cephalosporins, due to their production of beta-lactamase, may be susceptible to cefpodoxime.
FOR PRODUCT PORTFOLIO ◦ CEPODEM-XP (Cefpodoxime + Clavulanic Acid)
◦ CEROXIM (Cefuroxime)
◦ CEROXIM-XP (Cefuroxime + Clavulanic Acid)
◦ RACIPER (Esomeprazole)
◦ RICONIA (Multivitamin)
◦ ALTRAFLAM (Aceclofenac)
◦ SYNASMA (Doxofylline)
◦ & GEMBAX (Gemifloxacin)
To know the market share of the
Ranbaxy’s Products in Ranbaxy
(Pharma) Section.
To know about the current products that
are giving a tough competition to
Ranbaxy.
To know about the new competitors that
have entered into the market and are
trying to capture some of it’s share.
1
2
3
Type of Research: Exploratory research
Sample unit: Retailer
Sample extent: South Delhi
Sampling technique: Convenient sampling
Sample size: 100 Retailers
Data collection methods:
Primary methods: (a)Face to face interactions (b) Questionnaire
Secondary methods: Company manuals ,Journals ,Magazines & Internet
Analysis technique
Microsoft Excel has been used for the statistical analysis.
Limitations:
Sometime respondents refuse to cooperate and it may possible that they give biased and dishonest answers.
SALE OF CEPODEM STRIP/WEEK
0
10
20
30
40
50
60
70
80
90
CEPODEM CEPODEM-XP CEROXIM CEROXIM-XP RACIPER RICONIA ALTRAFLAM-P SYNASMA GEMBAX
Ranbaxy Product sales/week
OVERALL AIIMS MALVIYA NAGAR CHITTARANJAN PARK
JANGPURA---BHOGAL NEW FRIENDS COLONY JAMIA NAGAR(OKHLA) OKHLA (FORTIS HOSPITAL)
Cost factor
Advertisement in medical journals.
More profit and replacement schemes to the chemists
Availability of products
Frequent Doctors Visit.